Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3446 per EA under NDC 57237008763. Its NADAC has been published 472 times since Aug 9, 2017.
FDA first approved this application on Dec 31, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237008763
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA202490FDA Approved
12/31/2012
TE Code
AB
On Market Since
12/31/2012
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 472 times since Aug 9, 2017, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3446 per EA |
|---|---|
| All-time high | $1.0560 (Aug 16, 2017) |
| All-time low | $0.3203 (Jul 17, 2024) |
| 52-week high | $0.5666 |
| 52-week low | $0.3446 |
| Median price | $0.6325 |
| Average price | $0.6580 |
| Largest weekly change | +74.4% (Aug 21, 2024) |
| Weeks tracked | 472 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3446 per EA (NDC 57237008763), effective Aug 19, 2026.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 67.4%. It has been tracked across 472 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Aug 9, 2017, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.0560 (Aug 16, 2017), with a median of $0.6325 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 7% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 57237008763) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.